Clinical Trials Logo

Clinical Trial Summary

This research seeks to determine if a combination of low-dose ibuprofen along with a structured home-based walking and progressive resistance exercise program, EXCAP, will be effective in reducing cognitive difficulties among cancer patients receiving chemotherapy.


Clinical Trial Description

To conduct a feasibility pilot to assess preliminary efficacy of a 6 week course of ibuprofen (200 mg BID with does 8 hours apart) and a structured home based walking/progressive resistance program, EXCAP, alone or together, on cognitive function and levels of inflammatory molecules among cancer patients receiving chemotherapy (beginning at cycle 2). If these interventions prove to be useful and have potential benefit, they could have a substantial impact on treating cognitive difficulties experienced by cancer patients as well as improve quality of life. Moreover, if there is an effect of these interventions on cognitive functioning and inflammation, we will gain more knowledge of a possible mechanism of chemotherapy-related cognitive difficulties. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01238120
Study type Interventional
Source University of Rochester
Contact
Status Completed
Phase Phase 2
Start date November 2010
Completion date December 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06267014 - Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity N/A
Not yet recruiting NCT05864274 - Improve Cancer-related Cognitive Impairment N/A
Completed NCT04667689 - An Online Cognitive Assessment in Cancer Patients N/A
Not yet recruiting NCT05333250 - Modafinil to Improve Fatiguability Phase 3